Methodology

All entries for: AAVantgarde Bio SRL

September 30, 2025

AAVantgarde Bio SRL

Orphan Drug Designation

FDA orphan drug designation: treatment of ABCA4 mutation-associated retinal dystrophy

Disease Area: Rare Diseases
Source
Facebook Linkedin
Main Menu
Scroll to Top